Dr
Sofie
McPherson

Patent Director

London Office

Electronics

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Sofie is a Chartered UK and European Patent Attorney and her work includes providing strategic advice on how to protect inventions and to deliver solutions that are commercially focused and relevant to the client. She easily adapts to her clients’ ways of working and takes a proactive role to support their needs.

Much of Sofie’s work is based around software in various industries, and she has particular experience of software in healthcare, finance, online gaming, mobile phone apps, live events displays, Internet-of Things, Machine-to-Machine and graphical user interface. Sofie also has great experience in Standard related work, in particular telecoms and 3GPP, and understands the technical and commercial relationship between technical standards, patents and patent applications. Much of Sofie’s experience has been in relation to security related inventions in 4G and 5G.

Sofie graduated with a First class degree in Materials Engineering in Medicine, and has a PhD in Biomaterials with focus on developing and characterisation of synthetic bone grafts. She has practical and academic experience in tissue engineering, electron microscopy and material characterisation systems including raman spectroscopy and fourier-transform infrared spectroscopy. She has also worked with clients seeking patent protection for their medical devices.

Qualifications

Patent Attorney

Chartered (UK)
European


MENG

Materials Engineering in Medicine

PHD

Biomaterials

Publications

UK Supreme Court Reaches a Unanimous decision in Parallel Unwired Planet and Conversant Appeal cases, Spelling Victory for Standard Essential Patent Holders

View publication online

Conferences: 2021

December 9th 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

Speaker

Event details

May 25th 2021

IAM webinar: How to capitalise on the 5G healthcare revolution

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Related News

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details
Event - 10th March 2022

Manufacturing & Supply Chain Conference 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.